Ozempic’s Success Is Bad News for Rivals
Bloomberg Businessweek
00:00
GLP1 Receptor Agonists: Revolutionizing Diabetes Treatment and Weight Loss
Discover the groundbreaking effects of GLP1 receptor agonists in treating diabetes and promoting weight loss, and learn about the challenges in drug approval and insurance coverage.
Play episode from 02:07
Transcript
